News
Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective ...
Epic Systems has introduced a new initiative called Launchpad. This initiative, according to a May 22 LinkedIn post from Epic, is designed to help healthcare organizations implement generative ...
Clinical trials are a crucial step in medical research, and without adequate numbers of participants, treatments can be ...
AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD), joining ...
Checkmarx, the leader in autonomous application security for the enterprise, will demonstrate its agentic AI vision and discuss its implications for closing the speed gap between security and software ...
Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...
Bernstein analysts reaffirmed their Market Perform rating and $30 price target for Pfizer Inc. (NYSE:PFE) on May 20, ...
If you’re anything like me, what finally made you stop rolling your eyes at the term “artificial intelligence” was OpenAI’s ...
AI is racing into healthcare, but most organizations are still stuck at the starting line. | Despite all the AI hype, most ...
Artificial intelligence (AI) governance is a tricky topic in the health care industry. Stakeholders must collaborate to set ...
Dr. Brian Anderson of the Coalition for Health AI said there is "a real urgency" to ensure AI models are managed "robustly ...
The clinical trials are sponsored by IO Biotech and conducted in collaboration with Merck, which is supplying pembrolizumab. IO Biotech maintains global commercial rights to Cylembio. Cylembio ® is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results